Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-2,207
Closed -$244K – 224
2022
Q4
$244K Buy
+2,207
New +$231K 0.1% 159
2022
Q2
– Sell
-3,541
Closed -$302K – 237
2022
Q1
$302K Buy
3,541
+999
+39% +$95.7K 0.13% 151
2021
Q4
$305K Buy
+2,542
New +$315K 0.15% 153

Other funds holding XYL

ASB Consultores's XYL Position: Q1 2023 in Review

ASB Consultores sold out of Xylem (XYL) in Q1 2023, closing a stake of 2,207 shares — an estimated $244K sold.

ASB Consultores first reported a position in XYL in Q4 2021 and held it in 3 quarters. The position peaked at $305K in Q4 2021. 839 funds tracked by Wall St. Rank hold XYL as of Q1 2023.

  • ASB Consultores reported no remaining Xylem position as of Q1 2023 after selling out during the quarter.
  • ASB Consultores sold 2,207 Xylem shares in Q1 2023, an estimated $244K.
  • ASB Consultores first reported a position in Xylem in Q4 2021 and held it in 3 quarters.
  • ASB Consultores's Xylem position peaked at $305K in Q4 2021.
  • 839 funds tracked by Wall St. Rank held Xylem as of Q1 2023.

Based on ASB Consultores's 13F filing for Q1 2023, filed 3 May 2023.